Which of the following statement is not true regarding dobutamine
**Core Concept**
Dobutamine is a synthetic catecholamine that acts as a beta-adrenergic agonist, primarily stimulating beta-1 and beta-2 receptors, with minimal alpha-adrenergic activity. It is used in the management of heart failure, cardiogenic shock, and during stress echocardiography to assess cardiac function.
**Why the Correct Answer is Right**
Dobutamine increases contractility and heart rate by stimulating beta-1 receptors, which are predominantly found in the heart. This results in an increase in cardiac output, which is beneficial in patients with heart failure. Dobutamine also causes vasodilation due to its beta-2 receptor agonist activity, which can lead to a decrease in systemic vascular resistance.
**Why Each Wrong Option is Incorrect**
**Option A:** Dobutamine is not a pure beta-1 agonist; it has significant beta-2 agonist activity, which contributes to its vasodilatory effects.
**Option B:** Dobutamine is not typically used to treat hypertension; its vasodilatory effects can actually lead to hypotension in some patients.
**Option C:** Dobutamine is not a direct-acting vasopressor; its primary mechanism is through beta-adrenergic receptor stimulation, not direct vasoconstriction.
**Clinical Pearl / High-Yield Fact**
Dobutamine is often used in combination with nitrates to enhance its vasodilatory effects and reduce afterload in patients with heart failure.
**Correct Answer:** C. Dobutamine is not a direct-acting vasopressor.